Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autifony Therapeutics
Biotech
Jazz puts up $771M to form Autifony neuroscience discovery pact
GSK spinout Autifony has secured up to $770.5 million to discover drug candidates against ion channel targets associated with neurological disorders.
Nick Paul Taylor
Nov 14, 2023 9:40am
Boehringer nets option on Autifony schizophrenia drug
Dec 18, 2017 6:15am
EuroBiotech: More Articles of Note
Mar 16, 2017 9:14am
Pfizer-backed GSK spinout advances schizophrenia drug after PhI success
Aug 1, 2016 6:33am